Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 7/20 | 0.47 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.43 |
| ▸ | NPY4R | P50391 | 3/20 | 0.42 |
| ▸ | CTSL | P07711 | 3/20 | 0.42 |
| ▸ | CTSS | P25774 | 3/20 | 0.42 |
| ▸ | CTSK | P43235 | 3/20 | 0.42 |
| ▸ | NPY1R | P25929 | 2/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.42 |
| ▸ | MC4R | P32245 | 3/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
| ▸ | TUBB | P07437 | 1/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.41 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.41 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.41 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.41 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.41 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.41 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29605732 | 0.93 | QRFPR (0.48) | QRFPRC5AR1NPY4RNPY1RNPY5R | |
| SCHEMBL31412180 | 0.91 | QRFPR (0.45) | QRFPRC5AR1NPY4RNPY1RNPY5R | |
| SCHEMBL30746799 | 0.90 | C5AR1 (0.47) | QRFPRC5AR1MC4RAPLNRIL23R | |
| SCHEMBL30264590 | 0.88 | APLNR (0.47) | QRFPRC5AR1NPY4RNPY1RNPY5R | |
| SCHEMBL30037518 | 0.87 | IL23R (0.53) | CTSLCTSSCTSKMC4RIL23R | |
| SCHEMBL30121028 | 0.87 | QRFPR (0.56) | QRFPRNPY4RCTSLNPY1RNPY5R | |
| SCHEMBL29591802 | 0.87 | QRFPR (0.54) | QRFPRNPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29590985 | 0.87 | QRFPR (0.56) | QRFPRNPY4RCTSLNPY1RNPY5R | |
| SCHEMBL29630348 | 0.87 | QRFPR (0.53) | QRFPRNPY4RCTSLNPY1RNPY5R | |
| SCHEMBL30481160 | 0.84 | QRFPR (0.64) | QRFPRNPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310521-A1 | COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-10-05 | — | — | US | disclosed |
| WO-2023192262-A1 | A COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-10-05 | — | — | WO | disclosed |
| US-11723919-B2 | Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723919-B2 | Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D | VDR, CYP24A1, GC | QRFPR 3689/4885C5AR1 1463/4885NPY4R 3625/4885 |
| US-20230310521-A1 | COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING | CHIA, YBX3, XPA | QRFPR 192/4885C5AR1 984/4885NPY4R 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.